Riskpilot← Back to searchSign inGet full accessBIOSENSE ApS
APSActiveCVR 20830735Vidågade 28Wholesale of china and glassware and cleaning materials · NACE 4644Est. 19981 employeesBiosense.dk
Revenue 2024
DKK 125K
-47% vs 2023
EBITDA margin
-44.3%
-229% vs 2023
Equity ratio
68.5%
Financial strength
Net profit 2024
DKK -43K
-231% vs 2023
| Revenue | DKK 125K | -47% |
| EBITDA | DKK -55K | -229% |
| Net profit | DKK -43K | -231% |
| Total assets | DKK 1M | -5% |
| Equity | DKK 691K | -6% |
| Employees | 1 | — |
Legal name
BIOSENSE ApS
CVR number
20830735
Legal form
Anpartsselskab
NACE code
4644 · Wholesale of china and glassware and cleaning materials
Founded
1. marts 1998
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er handelsvirksomhed med import og salg af produkter med et højt teknologisk eller bioteknologisk videnindhold til rengøring og desinfektion m.v. til hosholdninger og industrien, samt anden dermed i forbindelse stående virksomhed efter direktionens skøn
Address
Vidågade 28
Email
Biosense@outlook.dk
Website
Biosense.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 199 | 192 | 198 | 239 | 139 | 107 | 19 | 68 | -2 | 194 | 237 | 125 |
| Staff expenses | -71 | -61 | -65 | -72 | -76 | -72 | -61 | -52 | -45 | -45 | -34 | -194 | -180 |
| EBITDA | 219 | 138 | 127 | 126 | 164 | 67 | 46 | -34 | 24 | -47 | 160 | 43 | -55 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -13 | -13 | -13 | -13 | -13 | -0 | -0 | -0 |
| EBIT | 219 | 138 | 127 | 126 | 164 | 53 | 33 | -47 | 10 | -60 | 160 | 43 | -55 |
| Net financials | 13 | 235 | 58 | 326 | -45 | 40 | -76 | 95 | 36 | -3 | -2 | -1 | 1 |
| Profit before tax | 232 | 373 | 185 | 452 | 119 | 94 | -43 | 48 | 46 | -63 | 157 | 42 | -55 |
| Tax | 58 | 94 | 47 | 106 | 26 | 19 | -6 | 11 | 10 | 3 | 17 | 9 | -12 |
| Net profit | 174 | 279 | 138 | 346 | 93 | 74 | -37 | 37 | 36 | -66 | 140 | 33 | -43 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 516 | 789 | 748 | 1.067 | 1.026 | 1.091 | 1.067 | 1.050 | 958 | 704 | 791 | 1.058 | 1.008 |
| Equity | 392 | 622 | 662 | 940 | 962 | 1.037 | 1.000 | 929 | 855 | 675 | 701 | 733 | 691 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 123 | 167 | 86 | 127 | 64 | 55 | 67 | 121 | 103 | 29 | 90 | 325 | 317 |
| Total debt | 123 | 167 | 86 | 127 | 64 | 55 | 67 | 121 | 103 | 29 | 90 | 325 | 317 |
EBITDA margin
-44.3%
This company
15.8%
Market median
-380% vs market
20122024
Equity ratio
68.5%
This company
38.2%
Market median
+79% vs market
20122024
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20122024
Net profit margin
-34.3%
This company
8.1%
Market median
-523% vs market
20122024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20122024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 1998 | — | — |
ML Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
JM Management | Management | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
| Individual | 100.0% | 100.0% | 1998 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOSENSE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Bang Henriksen | Management | 0 companies |
| Marie Louise Refslund Hindrichsen | Chief Executive Officer | 0 companies |
| Janne Marcussen | Management | 0 companies |
| Anne Meta Refslund Hindrichsen | Board of Directors | 0 companies |